U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1999
175
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Approved
8583
equate ECZEMA RELIEF

Approved Use

Temporarily protects and helps relieve minor skin irritation and itching due to eczema and rashes.
Name Type Language
Palmitoyl Hexapeptide-12
INCI  
INCI  
Official Name English
Glycine, N-(1-oxohexadecyl)-L-valylglycyl-L-valyl-L-alanyl-L-prolyl-
Preferred Name English
Pal-Val-Gly-Val-Ala-Pro-Gly
Systematic Name English
N-(1-Oxohexadecyl)-L-valylglycyl-L-valyl-L-alanyl-L-prolylglycine
Systematic Name English
Code System Code Type Description
SMS_ID
300000055967
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
PUBCHEM
10212452
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
CAS
171263-26-6
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID401018159
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
RXCUI
1732116
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
DAILYMED
HO4ZT5S86C
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
FDA UNII
HO4ZT5S86C
Created by admin on Wed Apr 02 20:09:12 GMT 2025 , Edited by admin on Wed Apr 02 20:09:12 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966